On 30 April 2024, Piers Millett provided oral evidence on the biosecurity implications of engineering biology to the Lords Science and Technology Committee

IBBIS Executive Director, Piers Millett, helps celebrate the launch of this important new regional initiative

Anyone finding ways to circumvent gene synthesis screening needs to be responsible in how they share the knowledge.

A new paper explores the rationale and process to develop a prototype DNA synthesis screening test dataset, aiming to establish a baseline of screening system accuracy to compare with various screening approaches.

IBBIS is a first-of-its-kind organization to strengthen international biosecurity governance.

IBBIS Executive Director Dr. Piers Millett chaired the opening panel of SynbiTECH 2023 in London, UK on December 5

IBBIS selected as one of 10 initiatives to receive support from the Paris Peace Forum community to accelerate its efforts to strengthen biosecurity norms.

Dr. Piers Millett is a lead author on a journal article for Health Security that examines how the scientific community can begin to move past using lists of organisms for biosecurity controls.

Dr. Piers Millett argues for greater safeguards to protect the dangerous pathogens kept in labs around the world in a new Science Magazine editorial.

The new UK Government Biological Security Strategy explicitly recognized the important role played by IBBIS and the importance of DNA synthesis screening.

Dr. Millett participates in inaugural OECD Global Forum on Technology with more than 300 senior policymakers and leading technology experts to discuss "shaping our future at the tech frontier."

IBBIS Executive Director Piers Millett provided a progress update to the annual meeting of the Biosecurity Innovation and Risk Reduction Initiative.